5.1 Mechanism of intranasal delivery Since William Frey II proposed intranasal administration in 1991 (Frey, 1991), this technique has emerged as a novel, non-invasive delivery system, bypassing the BBB and the systemic first-pass effect, allowing rapid onset of action
Tepotinib in non-small-cell lung cancer with MET exon 14 skipping mutations
The New Hazlett Center for the Performing Arts and its affiliated companies have the right to discontinue, change or update any data, information or material included in the Website without prior notice, and the New Hazlett Center for the Performing Arts does not assume any legal liability or responsibility for the accuracy, completeness or usefulness of any data, information or material included in, or accessible from, this Website
Learn how to layer these compounds effectively for GI support, tissue repair, and weight management
10.1002/oby.22377 16